michigan glp-1 class action Glp1 Mechanism Of Glucagonlike Peptide Target Organs Stock Illustration - Download Image Now Hims & Hers launches Wegovy

Liver health The FDA recently approved the GLP-1 receptor agonist semaglutide (Wegovy) for the treatment of metabolic-associated steatohepatitis (MASH), a severe form of fatty liver disease that causes inflammation and scarring

While some patients experience diarrhea, most find the opposite, with slowed gastric emptying producing slower movement throughout the digestive system

They work by mimicking a hormone that reduces appetite and slows digestion

Less food noise : Reduce thoughts about food and cravings by targeting the brains reward system

Key Takeaway: Always prioritize the instructions printed on your specific medication label over general advice, especially with compounded medications tailored to your health profile